# Sustained Therapeutics Inc. — Form D/A

Sustained Therapeutics Inc. of VANCOUVER, A1, a company, filed a Form D amendment with the SEC on 2022-08-25. The offering totals $100K, of which $100K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2022-08-25
- Form: D/A
- Accession: 0001929737-22-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $100K
- Amount sold: $100K
- Minimum investment: $100K
- Investors: 1
- Date of first sale: 2022-05-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-446815

## Issuer

- Name: Sustained Therapeutics Inc.
- CIK: 0001929737
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 10TH FLOOR, VANCOUVER, A1, V6C 2T5
- Phone: 778-388-3612

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Martin Gleave | Director | Vancouver, A1 |
| Martin Gleave | Executive Officer | Vancouver, A1 |
| Carol Ammon | Director | Vancouver, A1 |
| Dennis Parolin | Director | Vancouver, A1 |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-09-26](https://search.stillhousedata.com/formd/0001929737-22-000003) | D/A | $100K | $100K |
| [2022-05-24](https://search.stillhousedata.com/formd/0001929737-22-000001) | D | $100K | $100K |

## More

- [CIK 1929737 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1929737&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001929737-22-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.